Science Explorer Back to mapMap
Discussion
Researcher · Jubilant Life Sciences (India) · India

Sreekanth Dittakavi

Sreekanth Dittakavi publishes mostly in Hematology, Molecular Biology and Genetics, on topics such as Chronic Lymphocytic Leukemia Research, Chronic Myeloid Leukemia Treatments and PI3K/AKT/mTOR signaling in cancer.

ORCID 0000-0002-5638-327X OpenAlex
World rank
#6,576,517
of 7,710,434 ranked researchers
Rank in India
#217,153
of 280,097
Works
38
Citations
240
Citations per work
6.3
h-index
8
i10-index 6Top 72% in Hematology
Sreekanth Dittakavi

What does Sreekanth Dittakavi research?

Sreekanth Dittakavi's work is mostly in Medicine (49%), Biochemistry, Genetics and Molecular Biology (18%), Immunology and Microbiology (7%).

Health Sciences: 19 works · 49.4% of their workMedicine: 19 works · 49.4% of their workHematology: 7 works · 17.9% of their workGenetics: 6 works · 16.8% of their workOncology: 4 works · 10.5% of their workPublic Health, Environmental and Occupational Health: 2 works · 4.2% of their workEverything else: 10 works · 25.3% of their workLife Sciences: 10 works · 25.3% of their workBiochemistry, Genetics and Molecular Biology: 7 works · 17.9% of their workMolecular Biology: 7 works · 17.9% of their workImmunology and Microbiology: 3 works · 7.4% of their workImmunology: 3 works · 7.4% of their workTHEIR WORKSreekanthDittakavi38works
Life Sciences25%Health Sciences49%

Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.

The fields and subfields, with their numbers
    1. Medicine1949.4%
  2. Everything else1025.3%
    1. Biochemistry, Genetics and Molecular Biology717.9%
    2. Immunology and Microbiology37.4%
  1. 1Hematology18% of their works
  2. 2Molecular Biology18% of their works
  3. 3Genetics17% of their works
  4. 4Oncology10% of their works
  5. 5Immunology7% of their works
  6. 6Public Health, Environmental and Occupational Health4% of their works

Research topics

Which keywords describe Sreekanth Dittakavi's research?

The keywords of their largest research topics: Prognostic Factors, Chronic Lymphocytic Leukemia, Genomic Aberrations, BCR-ABL, Imatinib, Metabolism, Biosimilars and Immunogenicity.

Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.

All 18 words, with their numbers
  1. Prognostic Factors223 topics
  2. Chronic Lymphocytic Leukemia131 topic
  3. Genomic Aberrations131 topic
  4. BCR-ABL101 topic
  5. Imatinib101 topic
  6. Metabolism92 topics
  7. Biosimilars61 topic
  8. Immunogenicity61 topic
  9. Signaling61 topic
  10. mTOR61 topic
  11. AML51 topic
  12. Acute Myeloid Leukemia51 topic
  13. Acute Lymphoblastic Leukemia41 topic
  14. Childhood Cancer41 topic
  15. BRCA Mutation31 topic
  16. PARP Inhibitors31 topic
  17. Resveratrol31 topic
  18. Sirtuins31 topic

Where does Sreekanth Dittakavi work?

Sreekanth Dittakavi's main affiliation in the publication record is Jubilant Life Sciences (India), India.

How many publications and citations does Sreekanth Dittakavi have?

OpenAlex counts 38 works and 240 citations for Sreekanth Dittakavi, an h-index of 8, ranking #6,576,517 of 7,710,434 researchers worldwide on the quality score.

Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.

Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.

Discussion

Ask a question or share a note about Sreekanth Dittakavi. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.